As an injectable compound, GHK-Cu was placed on the FDAs Category 2 bulk drug substance list in late 2023, restricting compounding pharmacies from preparing it
Researchers reported changes in selected subjective and observed symptoms, but the study lacked randomisation, blinding and a suitable comparison group
Future work will focus on refining the docking protocol and conducting in vitro and in vivo experiments to confirm the predicted interactions
Diet and exercise are always the first necessary steps to weight loss, and the effectiveness of lipotropic injections is heavily dependent on both of those factors
Digestive issues, such as indigestion, loss of appetite, or weight loss The digestive system relies on B vitamins for proper functioning
This protocol is a favorite among our fitness-focused patients using peptides for muscle growth